|
XRCC3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.61889998576237E-09 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.02460000039883E-07 |
| Normal-vs-Stage2 |
3.923600E-03 |
| Normal-vs-Stage3 |
1.025620E-04 |
| Normal-vs-Stage4 |
3.756400E-02 |
| Stage1-vs-Stage2 |
9.228600E-01 |
| Stage1-vs-Stage3 |
5.966600E-01 |
| Stage1-vs-Stage4 |
2.392200E-01 |
| Stage2-vs-Stage3 |
7.863400E-01 |
| Stage2-vs-Stage4 |
2.322600E-01 |
| Stage3-vs-Stage4 |
1.706830E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.55440002483454E-09 |
| Normal-vs-AfricanAmerican |
1.97846999999696E-05 |
| Normal-vs-Asian |
2.107600E-02 |
| Caucasian-vs-AfricanAmerican |
2.294200E-01 |
| Caucasian-vs-Asian |
6.721200E-01 |
| AfricanAmerican-vs-Asian |
9.982200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.70830000040456E-09 |
| Normal-vs-Female |
1.55960000025601E-07 |
| Male-vs-Female |
8.604600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.27189999999689E-05 |
| Normal-vs-Extreme_Weight |
2.5440999995574E-07 |
| Normal-vs-Obese |
8.10629999792312E-08 |
| Normal-vs-Extreme_Obese |
1.558470E-02 |
| Normal_Weight-vs-Extreme_Weight |
9.867000E-01 |
| Normal_Weight-vs-Obese |
2.950200E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.705000E-01 |
| Extreme_Weight-vs-Obese |
2.030400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
3.910200E-01 |
| Obese-vs-Extreme_Obese |
2.064000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.951800E-04 |
| Normal-vs-Age(41-60Yrs) |
3.94420052174382E-10 |
| Normal-vs-Age(61-80Yrs) |
1.0358000002153E-07 |
| Normal-vs-Age(81-100Yrs) |
7.460100E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.425200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.038400E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.833540E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.538000E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.341700E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.257220E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.04289926589263E-11 |
| Normal-VS-Type2 PRCC |
2.724400E-02 |
| Normal-VS-KIRP CIMP |
4.444700E-04 |
| Normal-VS-Unclassified PRCC |
1.7441399999929E-05 |
| Type1 PRCC-VS-Type2 PRCC |
6.78729999981087E-08 |
| Type1 PRCC-VS-KIRP CIMP |
8.478600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
6.160400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.118500E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
9.599300E-04 |
| KIRP CIMP-VS-Unclassified PRCC |
9.311000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.358400E-04 |
| Normal-vs-N1 |
3.69350000000157E-05 |
| Normal-vs-N2 |
4.010400E-01 |
| N0-vs-N1 |
1.207390E-01 |
| N0-vs-N2 |
3.730000E-01 |
| N1-vs-N2 |
1.362590E-01 |
|
|
